http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
AMRI Announces First Quarter 2017 Results
-
Albany Molecular Research (AMRI) Reports 5-Yr NIH Contract for Drug Substance Development & Manufacturing Svcs
-
AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services
-
AMRI Schedules First Quarter 2017 Earnings Release and Conference Call
-
AMRI Receives CMO Leadership Awards for Excellence
-
AMRI to Present at Barclays Global Healthcare Conference
-
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products
-
AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook
-
AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call
-
AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery
-
AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference
-
Albany Molecular Research (AMRI) Enters Multi-Year Supply Agreement with Shire
-
AMRI Announces API Supply Agreement with Shire
-
AMRI to Present Two Posters at AAPS 2016
-
AMRI Announces Third Quarter 2016 Results
-
AMRI Schedules Third Quarter 2016 Earnings Release and Conference Call
-
AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona
-
AMRI CEO to Present at Morgan Stanley Global Healthcare Conference
-
AMRI CEO to Present at Morgan Stanley Global Healthcare Conference
-
AMRI CEO to Present at Baird 2016 Global Healthcare Conference
-
AAMRI (AMRI) Enters License Agreement for CRISPR-Cas9 Gene Editing Technology
-
AMRI Licenses CRISPR-Cas9 Gene Editing Technology
-
AMRI to Announce Second Quarter 2016 Results
-
Albany Molecular Research (AMRI) Announces Completion of Euticals Acquisition
-
AMRI Completes Acquisition of Euticals
-
Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and Sale of the First Commercially Available CBCA Analytical Standard
-
AMRI Selected as a Dedicated Chemical Biology Consortium Center to Expand Drug Development
-
AMRI CEO to Present at Jefferies 2016 Healthcare Conference
-
AMRI Appoints Louis Yu, Ph.D., as Senior Vice President, Quality and Compliance
-
AMRI (AMRI) to Acquire Euticals $358M Deal
-
AMRI to Acquire Euticals in a Strategic Transaction That Expands its API Development and Manufacturing Business
-
AMRI to Announce First Quarter 2016 Results
-
AMRI Announces Filing of Annual Report on Form 10K
-
AMRI Wins Four Life Science Leader Awards
-
AMRI Announces Extension to File Form 10K for 2015
-
AMRI to Announce Fourth Quarter and Full Year 2015 Results
-
AMRI and NYCNMR Form Collaborative Agreement
-
Albany Molecular Research (AMRI) Receives Extension of Key Insourcing Relationship
-
AMRI Announces 3-Year Extension of Insourcing Contract
-
Albany Molecular Research (AMRI), Eagle Pharma (EGRX) Enter Parenteral Drug Products R&D Collaboration
-
Eagle Pharmaceuticals and AMRI Announce Agreement to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products
-
AMRI Announces First Product Approval Out of its Massachusetts Aseptic Fill Finish Site
-
AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation
-
Albany Molecular Research (AMRI), Icagen Sign Collaboration Agreement
-
AMRI and Icagen Ink Collaboration Agreement
-
AMRI CEO to Present at the 34th Annual J.P. Morgan Healthcare Conference
-
AMRI (AMRI) Acquires Whitehouse Labs in $56M Deal
-
AMRI Acquires Whitehouse Laboratories
-
AMRI (AMRI) Debuts New U.S.-Based Integrated Drug Discovery Center
-
AMRI Launches its U.S. Integrated Drug Discovery Center